Low-protein meals during immunotherapy for cancer patients
Part of Cancer clinical trials.
This trial tests whether eating low-protein meals helps people with metastatic cancer feel better or tolerate immunotherapy (immune checkpoint inhibitors). It’s mainly a pilot/feasibility study, meaning the goal is to see if the diet is safe and doable during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older with a solid tumor cancer that can be treated with immunotherapy that blocks PD-1, PD-L1, and/or CTLA-4
- Your cancer has spread to soft tissue and/or bones, confirmed by scans (CT and/or bone scan)
- You have at least 6 months of expected life expectancy (as judged by your care team)
- Your blood counts and organ labs meet minimum thresholds (white cells, neutrophils, platelets, hemoglobin) and your kidney/liver tests are not too abnormal
- You are well enough to do daily activities: your performance status must be better than ECOG 2
- You haven’t had certain medicines or infections recently (especially strong steroids or significant infections), and you must be able to get CT contrast dye if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This pilot study tests whether alternating periods of lower calorie intake, along with a plant-based diet, is safe and feasible for people receiving chemotherapy. If it helps, it could support better comfort and treatment tolerance during cancer therapy.
This study tests whether a change in diet can help people with early-stage melanoma or lung cancer who are receiving immunotherapy (a type of treatment that helps your immune system fight cancer). You will be asked to follow a diet, give blood and stool samples, and complete questionnaires to see how the diet affects your body and treatment.
This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.
This trial tests whether a special low-calorie 'fasting-mimicking' diet can reduce side effects from common immunotherapy drugs for advanced cancer. If you're on a PD-1, PD-L1, or CTLA-4 inhibitor, this diet might help you feel better during treatment.
This trial tests whether adding nutrition support helps cancer patients with malnutrition respond better to immunotherapy. You may be able to join if you have cancer and are malnourished, are generally active, and can swallow pills.
This trial tests whether a special prebiotic diet can help your body's bacteria (microbiome) better respond to standard immunotherapy for advanced melanoma that cannot be removed by surgery. If you are starting your first immunotherapy, you may be able to join.
Hear when a new Medical Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.